Risk of venous thromboembolism in users of contraception and menopausal hormone therapy during the COVID-19 pandemic.
Published in Revista da Associação Médica Brasileira
The outbreak of coronavirus disease (COVID-19) is a public health emergency of international concern. Inflammatory changes are part of COVID-19 pathophysiology and this might generate a higher thromboembolic risk in patients using combined hormonal contraception and menopausal hormone therapy. We aimed to discuss the main aspects related to this is...
